Literature DB >> 23883127

Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.

David Julian McClements1.   

Abstract

Nanoemulsions have considerable potential for encapsulating, protecting and delivering lipophilic bioactive components via the oral route, such as pharmaceuticals (drugs) and nutraceuticals (food components with specific health benefits). These systems can be fabricated from generally recognized as safe ingredients using relatively simple processing operations, such as mixing and homogenization. Some of the potential advantages of nanoemulsions over conventional emulsions include higher bioaccessibility, higher physical stability and higher optical clarity. An overview of the current status of nanoemulsion fabrication, stability, properties and biological fate is given, with special emphasis on the suitability of nanoemulsions for the oral delivery of hydrophobic bioactive components, such as drugs and nutraceuticals.

Mesh:

Substances:

Year:  2013        PMID: 23883127     DOI: 10.4155/tde.13.46

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  10 in total

1.  Nanosuspended branched chain amino acids: the influence of stabilizers on their solubility and colloidal stability.

Authors:  Chi Rac Hong; Gyu Whan Lee; Hyun-Dong Paik; Pahn-Shick Chang; Seung Jun Choi
Journal:  Food Sci Biotechnol       Date:  2017-05-29       Impact factor: 2.391

2.  A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied.

Authors:  Chang-Shun Liu; Xiao-Ying Long; Jing-Yi Ye; Zhong-Yun Chen; Chuan-Li Huang; Bei Huang; Yu-Rong Zheng; Ying-Feng Zhang; Ban-Yi Lu; Lin He
Journal:  Int J Nanomedicine       Date:  2020-08-26

Review 3.  Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials.

Authors:  Susann Bellmann; David Carlander; Alessio Fasano; Dragan Momcilovic; Joseph A Scimeca; W James Waldman; Lourdes Gombau; Lyubov Tsytsikova; Richard Canady; Dora I A Pereira; David E Lefebvre
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-30

Review 4.  Current approaches in lipid-based nanocarriers for oral drug delivery.

Authors:  María Plaza-Oliver; Manuel Jesús Santander-Ortega; María Victoria Lozano
Journal:  Drug Deliv Transl Res       Date:  2021-02-02       Impact factor: 4.617

5.  Nanoliposomes and Nanoemulsions Based on Chia Seed Lipids: Preparation and Characterization.

Authors:  Daria V Kuznetcova; Michel Linder; Carole Jeandel; Cedric Paris; Frederic Desor; Denis A Baranenko; Liudmila A Nadtochii; Elmira Arab-Tehrany; Frances T Yen
Journal:  Int J Mol Sci       Date:  2020-11-29       Impact factor: 5.923

Review 6.  The Current State of Knowledge on Salvia hispanica and Salviae hispanicae semen (Chia Seeds).

Authors:  Sara Motyka; Katarzyna Koc; Halina Ekiert; Eliza Blicharska; Katarzyna Czarnek; Agnieszka Szopa
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

7.  Fabrication of nanoemulsion delivery system with high bioaccessibility of carotenoids from Lycium barbarum by spontaneous emulsification.

Authors:  Chunlan Zhang; Bin Li
Journal:  Food Sci Nutr       Date:  2022-04-20       Impact factor: 3.553

8.  The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.

Authors:  Morteza Yaghoobian; Azadeh Haeri; Noushin Bolourchian; Soraya Shahhosseni; Simin Dadashzadeh
Journal:  Int J Nanomedicine       Date:  2020-11-11

Review 9.  Recent insights into the biological activities and drug delivery systems of tanshinones.

Authors:  Yuee Cai; Wenji Zhang; Zirong Chen; Zhi Shi; Chengwei He; Meiwan Chen
Journal:  Int J Nanomedicine       Date:  2016-01-05

Review 10.  The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment.

Authors:  Yiling Wang; Audrey Minden
Journal:  Cells       Date:  2021-12-17       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.